Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 11, 2026

Warren Buffett once explained how to turn $10K into a fortune for new investors. 3 strategies that still hold up in 2026

View original at finance.yahoo.com
Warren Buffett once explained how to turn $10K into a fortune for new investors. 3 strategies that still hold up in 2026 Bill Pugliano / Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Getting to first $100,000 is the hardest part and requires being passionate about rationality, eager and opportunistic, and steadily underspending income

    80% confidence
  • Moby's stock recommendations have beaten the S&P 500 by almost 12% on average over four years across almost 400 picks

    80% confidence
  • Wealth building works like a snowball rolling down a hill due to compound interest

    80% confidence
  • Investors must be prepared for stocks to decline 50% or more and be comfortable holding through volatility

    80% confidence
  • Success comes from staying smart in specific areas rather than trying to be a genius everywhere

    80% confidence
  • If starting with $10,000 today, would focus on smaller companies because working with smaller sums means more chance something is overlooked

    80% confidence
  • Total cost of owning and operating a new vehicle in 2025 is around $12,297 per year or $1,024.71 per month

    80% confidence
  • Car insurance rates can be as low as $29 per month through comparison shopping

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com